Addictions, Drug & Alcohol Institute


December 11, 2019

Research Suggests Naloxone May Be Good Past Its Expiration Date

Narcan nasal spray

Naloxone products typically have an expiration date (“shelf life”) approximately 18-24 months from the date of manufacture. Expiration dates are based on how long a manufacturer guarantees the full potency and safety of a drug. Two peer reviewed articles have tested the stability of naloxone: A 2006 article examined the stability of an array of…

December 10, 2019

Bia Carlini Named Director, UW Tobacco Studies Program

Dr. Bia Carlini, PhD, MPH, has been named as the new director of the Tobacco Studies Program in the School of Public Health, beginning December 15, 2019. Her earlier participation in the TSP convinced her to focus her career on tobacco control: as part of the first cohort of tobacco scholars, (2003-4), her tobacco-related practicum…

December 2, 2019

UW Researchers Find Clue to Preventing Addiction Relapse

Susan Ferguson

A study by ADAI Director Dr. Susan Ferguson was able to control relapse to heroin use in rats by using chemogenetic receptors to act as a “light switch” on neurons in the nucleus accumbens region of the brain. This process could prevent relapse for other addictions, like compulsive gambling or overeating, which affect the same…

November 25, 2019

Inside One of Seattle’s Biggest Opioid Busts

ADAI scientist Caleb Banta-Green was interviewed for a fascinating story about the drug fentanyl, and the multi-state effort to bring down a leading drug dealer in Seattle. Read the full story at Seattle Met . . .

November 14, 2019

Speaking from the Heart: The Parent-Child Assistance Program (PCAP)

Title screen of video "Speaking from the Heart"

The Parent-Child Assistance Program (PCAP) is an award-winning home visitation case‐management intervention working with a challenging population: pregnant and parenting women who have substance use disorders and trauma histories. Begun in 1991 at the University of Washington, PCAP now operates in fifteen counties throughout Washington State with the goals of helping mothers build healthy families…

Highly Potent Opioid Carfentanil Found in Seattle

Carfentanil, an opioid 10,000 times more potent than morphine and 100 times stronger than fentanyl, is showing up in Seattle with increasing frequency. In a KOMO News interview, ADAI principal scientist Caleb Banta-Green warns that users don’t know what they’re getting, or the dangers of this drug. View the full story on KOMO News. In…

November 5, 2019

“You don’t cure addiction — you manage it,” says ADAI scientist in interview with Variety.

Caleb Banta-Green, ADAI principal research scientist, told the entertainment news source Variety that “You don’t cure addiction — you manage it actively with counseling. You need to create a new life and a new way of interacting with people in a way that is healthy for you.” The interview was published on November 5 in Variety‘s Recovery…

October 22, 2019

Washington’s Ban on Nicotine Vaping Products is a “Stopgap Public-Health Imperative”

In an op-ed published in the Seattle Times, ADAI research scientist Bia Carlini and WSU professor Laura Hill challenge an earlier column that downplayed the appropriateness of Washington’s ban on nicotine vaping products. Noting the lack of research into these unregulated and widely-available products which have been linked to illnesses in hundreds of individuals and…

“Treat Us Like Human Beings”: New ADAI Report Features Interviews with Syringe Exchange Participants

two men sitting and talking at sunset

A new brief from Alison Newman, MPH, Connor Henry, MPH, and Caleb Banta-Green, PhD, MPH, MSW, “Treat us like individual human beings”: 2018 qualitative interviews with Washington State syringe exchange participants,” is now available on our Publications & Reports page. To get a richer understanding of the lives of syringe exchange participants, the authors conducted…

October 18, 2019

Sign Up to Get a Monthly Summary of New Opioid/Overdose Research

Person holding cell phone with email app

Susan Kingston of the Alcohol & Drug Abuse Institute puts out a monthly email newsletter that features the latest in opioid and overdose-related research and commentary. If you’re interested in subscribing, send an email to Here’s what was featured in the October 2019 issue: From Local Researchers Engaging an unstably housed population with low-barrier…

Previous page Next page